UREAPHIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ureaphil, and what generic alternatives are available?
Ureaphil is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in UREAPHIL is urea. There are thirty-three drug master file entries for this compound. Additional details are available on the urea profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for UREAPHIL?
- What are the global sales for UREAPHIL?
- What is Average Wholesale Price for UREAPHIL?
Summary for UREAPHIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 216 |
| DailyMed Link: | UREAPHIL at DailyMed |
US Patents and Regulatory Information for UREAPHIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | UREAPHIL | urea | INJECTABLE;INJECTION | 012154-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
